The Healthletic BPC-157 supplement referenced throughout this article is not approved by the U.S
Angiostatin Angiostatin, an endogenous inhibitor of angiogenesis, can block the growth of new blood vessels through a negative feedback homeostasis process (Cheng, et al
Al also tested the potential of IGF-1 DES to prevent increased vascular endothelial growth factor (VEGF) immunoreactivity
Nat Chem Biol 13(1):8190 Ye Z et al (2020) Abrogation of ARF6 promotes RSL3-induced ferroptosis and mitigates gemcitabine resistance in pancreatic cancer cells
Companies are now racing to use that phenomenon for a new form of rejuvenation medicine
References 1.Sikiric P., Rucman R., Turkovic B., Sever M., Klicek R., Radic B., Drmic D., Stupnisek M., Misic M., Vuletic L.B., et al